Commentary on "Increasing Minority Participation in Clinical Research": A White Paper from The Endocrine Society

Simple item page
dc.contributor.authorAlexander-Bridges, M.
dc.contributor.authorDoan, L. L.
dc.date.accessioned2019-08-14T15:04:56Z
dc.date.available2019-08-14T15:04:56Z
dc.date.issued2007
dc.description.abstractUnderrepresentation of racial and ethnic minorities in clinical research limits the applicability of trial results to diverse subpopulations. Recognizing an ongoing need to increase participation by minorities, The Endocrine Society established a task force of thought leaders from all stakeholder groups—the pharmaceutical industry, federal agencies, academia, and community groups—to develop a white paper outlining recommendations for meeting this need. The primary goal is to ensure that clinical research supporting the safety and efficacy of pharmaceutical products and the validity of biomarkers used to design therapeutic strategies is based on statistically powered data derived from minority subpopulations. To realize…
dc.description.urihttp://dx.doi.org/10.1210/jc.2007-2172
dc.identifierhttps://doi.org/10.13016/yibe-8zc7
dc.identifier.citationAlexander-Bridges, M. and Doan, L. L. (2007) Commentary on "Increasing Minority Participation in Clinical Research": A White Paper from The Endocrine Society. Journal of Clinical Endocrinology & Metabolism, 92 (12). pp. 4557-4559.
dc.identifier.issn0021-972X
dc.identifier.otherEprint ID 3211
dc.identifier.urihttp://hdl.handle.net/1903/23813
dc.subjectHealth Equity
dc.subjectPharmacotherapy
dc.subjectPolicy
dc.subjectResearch
dc.subjectracial and ethnic minorities
dc.subjectclinical research
dc.titleCommentary on "Increasing Minority Participation in Clinical Research": A White Paper from The Endocrine Society
dc.typeArticle

Files

Collections

Minority Health and Health Equity Archive